Levels of Serum and Cerebrospinal Fluid Enolase in the Patients With Cerebral Vascular Disease and Other Neurological Diseases.

Nosotchu
doi 10.3995/jstroke.10.313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Stroke Society

Related search

Cerebrospinal Fluid Analysis in Dogs and Cats With Neurological Diseases

Acta Scientiae Veterinariae
Veterinary
2019English

Cerebrospinal Fluid and Serum Uric Acid Levels in Patients With Multiple Sclerosis

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2009English

Levels of Neurospecific Enolase and Enolase-Specific Autoantibodies in Blood Serum of the Patients With Autoimmune Thyropaties

Medical Immunology (Russia)
AllergyImmunology
2014English

Comparison of Cerebellomedullary and Lumbar Cerebrospinal Fluid Analysis in Dogs With Neurological Disease

Journal of Veterinary Internal Medicine
MedicineVeterinary
2020English

Serum and Cerebrospinal Fluid S100B Concentrations in Patients With Neurocysticercosis

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2006English

CXCL13 and Neopterin Concentrations in Cerebrospinal Fluid of Patients With Lyme Neuroborreliosis and Other Diseases That Cause Neuroinflammation

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Proteinase-Activated Receptor 2 and Disease Biomarkers in Cerebrospinal Fluid in Cases With Autopsy-Confirmed Prion Diseases and Other Neurodegenerative Diseases

BMC Neurology
MedicineNeurology
2015English

Neuron-Specific Enolase Is a Marker of Cerebral Ischemia and Infarct Size in Rat Cerebrospinal Fluid

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1988English

Opsonic Activity of Serum, Acites Fluid, and Cerebrospinal Fluid in Various Disease

Ensho
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy